Ingrid Cornax

Head, Nonclinical Drug Safety Assessment, Altos Labs

Ingrid Cornax (DVM, PhD, MS, DACVP) is a veterinary pathologist with a PhD in Immunology. She completed her graduate and veterinary professional school training at UC Davis School of Veterinary Medicine. After graduation, she performed virology, microbiology, and recombinant antibody engineering research at the USDA, at UC San Diego School of Pharmcology, and at Roche Diagnostics in Penzberg, Germany. She completed her pathology specialty training at Louisiana State University and a comparative pathology research fellowship at the University of Minnesota Masonic Cancer Center. She currently works as the Head of Nonclinical Drug Safety Assessment at Altos Labs and has special interest and expertise in emerging gene and cell therapy safety research.

Blogs from Ingrid Cornax

Living Drugs: Investigating a Path to Safer Adoptive Cell Therapies

Discover how scientists are transforming cancer treatment with "living drugs," powerful immune cells trained to target and destroy cancer cells, while using a patient-centered approach to drug safety.

Blog provider: Sage Perspectives